• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin.

作者信息

Cooper M A, Nye K, Andrews J M, Wise R

机构信息

Department of Medical Microbiology, Dudley Road Hospital, Birmingham, UK.

出版信息

J Antimicrob Chemother. 1990 Oct;26(4):533-8. doi: 10.1093/jac/26.4.533.

DOI:10.1093/jac/26.4.533
PMID:2174853
Abstract

The pharmacokinetics of azithromycin were determined during a 24 h period following oral administration of a single 500-mg dose to each of six male volunteers. Concentrations in serum, urine and cantharides-induced inflammatory fluid were determined by microbiological assay. The mean peak serum concentration of 0.45 mg/l was obtained at a mean time of 2.6 h post-administration. The elimination half-life from serum was seen to increase with time post-dose; the mean elimination half-life at 16 h post-dose was 9.6 h. Inflammatory fluid was penetrated rapidly, with the mean peak concentration of 0.13 mg/l achieved at a mean time of 3.25 h post-dose. After this peak, levels initially decreased, but after 8 h from drug administration until the end of the trial period, inflammatory fluid concentrations remained relatively constant. The mean inflammatory fluid penetration up to the end of the study period was 74%. The mean urinary recovery of azithromycin, during the initial 24 h post-dose, was 6%.

摘要

相似文献

1
The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin.
J Antimicrob Chemother. 1990 Oct;26(4):533-8. doi: 10.1093/jac/26.4.533.
2
[Skin penetration of sulfamethoxazole and trimethoprim after oral administration].口服给药后磺胺甲恶唑和甲氧苄啶的皮肤渗透情况
Ann Acad Med Stetin. 2002;48:59-73.
3
The comparative pharmacokinetics and tissue penetration of single-dose ciprofloxacin 400 mg i.v. and 750 mg po.单剂量静脉注射400毫克环丙沙星与口服750毫克环丙沙星的比较药代动力学及组织穿透性。
J Antimicrob Chemother. 1994 Jan;33(1):103-10. doi: 10.1093/jac/33.1.103.
4
Pharmacokinetics and inflammatory fluid penetration of sparfloxacin.司帕沙星的药代动力学及炎性液体渗透情况
Antimicrob Agents Chemother. 1992 Nov;36(11):2444-6. doi: 10.1128/AAC.36.11.2444.
5
Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone.新型三氟喹诺酮Ro 23-6240的药代动力学和组织穿透性
Antimicrob Agents Chemother. 1987 Feb;31(2):161-3. doi: 10.1128/AAC.31.2.161.
6
Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219).曲伐沙星(CP-99,219)的药代动力学及在炎性液中的渗透情况
Antimicrob Agents Chemother. 1996 Jan;40(1):47-9. doi: 10.1128/AAC.40.1.47.
7
Pharmacokinetics and tissue penetration of orally administered pefloxacin.口服培氟沙星的药代动力学及组织穿透性
Eur J Clin Microbiol. 1987 Oct;6(5):521-4. doi: 10.1007/BF02014239.
8
Azithromycin pharmacokinetics and penetration to lymph.
Scand J Infect Dis Suppl. 1992;83:15-21.
9
Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose.单次口服吉米沙星后的药代动力学及组织穿透性
J Antimicrob Chemother. 2001 Apr;47(4):431-4. doi: 10.1093/jac/47.4.431.
10
A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose.
J Antimicrob Chemother. 1999 Nov;44(5):701-4. doi: 10.1093/jac/44.5.701.

引用本文的文献

1
Pharmacokinetics and Bioequivalence of Two Powders of Azithromycin for Suspension: A Nonblinded, Single-Dose, Randomized, Three-Way Crossover Study in Fed and Fasting States Among Healthy Chinese Volunteers.两种阿奇霉素干混悬剂的药代动力学与生物等效性:一项在中国健康志愿者中进行的非盲、单剂量、随机、三交叉试验,考察进食和空腹状态。
Drugs R D. 2024 Dec;24(4):517-529. doi: 10.1007/s40268-024-00492-4. Epub 2024 Oct 21.
2
Impact of First-Line Antimicrobials on -Induced Changes in Host Metabolism and Cytokine Production.一线抗菌药物对宿主代谢和细胞因子产生诱导变化的影响。
Front Microbiol. 2021 Aug 13;12:676747. doi: 10.3389/fmicb.2021.676747. eCollection 2021.
3
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis.
囊性纤维化中非结核分枝杆菌药物治疗的临床药代动力学和药效学考虑因素。
Clin Pharmacokinet. 2021 Sep;60(9):1081-1102. doi: 10.1007/s40262-021-01010-4. Epub 2021 May 13.
4
Measurement of tissue azithromycin levels in self-collected vaginal swabs post treatment using liquid chromatography and tandem mass spectrometry (LC-MS/MS).采用液相色谱-串联质谱法(LC-MS/MS)测定治疗后自行采集的阴道拭子中的组织阿奇霉素水平。
PLoS One. 2017 May 12;12(5):e0177615. doi: 10.1371/journal.pone.0177615. eCollection 2017.
5
Impact of a low-oxygen environment on the efficacy of antimicrobials against intracellular Chlamydia trachomatis.低氧环境对抗微生物药物治疗沙眼衣原体细胞内感染疗效的影响。
Antimicrob Agents Chemother. 2011 May;55(5):2319-24. doi: 10.1128/AAC.01655-10. Epub 2011 Feb 14.
6
Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.住院儿科患者常用的抗菌和抗真菌药物:基于临床药代动力学对治疗的影响
Paediatr Drugs. 2001;3(10):733-61. doi: 10.2165/00128072-200103100-00003.
7
Potentiation of antifungal activity of amphotericin B by azithromycin against Aspergillus species.
Eur J Clin Microbiol Infect Dis. 1997 Nov;16(11):846-8. doi: 10.1007/BF01700417.
8
New pharmacokinetic in vitro model for studies of antibiotic activity against intracellular microorganisms.用于研究抗生素对细胞内微生物活性的新型体外药代动力学模型。
Antimicrob Agents Chemother. 1996 Dec;40(12):2727-31. doi: 10.1128/AAC.40.12.2727.
9
Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections.阿奇霉素。对其药理特性及在呼吸道感染中作为三日疗法应用的综述。
Drugs. 1996 Mar;51(3):483-505. doi: 10.2165/00003495-199651030-00013.
10
Azithromycin clinical pharmacokinetics.
Clin Pharmacokinet. 1993 Nov;25(5):370-4. doi: 10.2165/00003088-199325050-00003.